Community-reported insights only, not medical advice. Data recency varies by source; check timestamps and confidence before making treatment decisions.

← Back to Brands

Greyscales

Community footprint analysis based on portfolio size and patient feedback.

Time Period:
Rank
60
Portfolio
4 Strains
Mentions (90d)
49
Brand Score (90d)
59
vs Market Avg: 63 vs All Time: 60
Below Average

Rating lower than the 90d community baseline.

Medication Portfolio (4)

Rank Strain Name Specs Mentions (90d) Score (90d) Historical Avg
98
25.0%
16
51
59
245
24.0%
16
62
62
319
27.0%
9
70
70
328
OZK
29.0%
8
55
55